161
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Plasma Total Homocysteine Level in Association With Folate, Pyridoxine, and Cobalamin Status Among Iranian Primary Breast Cancer Patients

, , , &
Pages 1097-1108 | Received 29 Aug 2013, Accepted 12 Jun 2014, Published online: 26 Aug 2014

REFERENCES

  • Chou YC, Lee MS, Wu MH, Shih HL, Yang T, et al.: Plasma homocysteine as a metabolic risk factor for breast cancer: findings from a case–control study in Taiwan. Breast Cancer Res Treat 101, 199–205, 2007.
  • Loscalzo J: Homocysteine trials–clear outcomes for complex reasons. N Engl J Med 354, 1629–1632, 2006.
  • Gupta A, Moustapha A, Jacobsen DW, Goormastic M, Tuzcu EM, et al.: High homocysteine, low folate, and low vitamin B6 concentrations: prevalent risk factors for vascular disease in heart transplant recipients. Transplantation 65, 544–550, 1998.
  • Konstantinova SV, Vollset SE, Berstad P, Ueland PM, Drevon CA, et al.: Dietary predictors of plasma total homocysteine in the Hordaland Homocysteine Study. Brit J Nutr 98, 201–210, 2007.
  • Pirouzpanah S, Taleban FA, Abadi AR, Atri M, and Mehdipour P: The association of plasma folate, vitamin b12 and homocysteine levels on hypermethylation status of RARβ2 gene in primary breast carcinoma. Iran J Epidemiology 5, 19–27 (Persian), 2009.
  • Pirouzpanah S, Taleban FA, Atri M, Abadi AR, and Mehdipour P: The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer. Cancer Cause Control 21, 2101–2111, 2010.
  • Duthie SJ: Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis 34, 101–109, 2011.
  • Kotsopoulos J, Medline A, Renlund R, Sohn KJ, Martin R, et al.: Effects of dietary folate on the development and progression of mammary tumors in rats. Carcinogenesis 26, 1603–1612, 2005.
  • Ferroni P, Palmirotta R, Martini F, Riondino S, Savonarola A, et al.: Determinants of homocysteine levels in colorectal and breast cancer patients. Anticancer Res 29, 4131–4138, 2009.
  • Wu LL and Wu JT: Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin Chim Acta 322, 21–28, 2002.
  • Gatt A, Makris A, Cladd H, Burcombe RJ, Smith JM, et al.: Hyperhomocysteinemia in women with advanced breast cancer. Int J Lab Hematol 29, 421–425, 2007.
  • Lin J, Lee IM, Song Y, Cook NR, Selhub J, et al.: Plasma homocysteine and cysteine and risk of breast cancer in women. Cancer Res 70, 2397, 2010.
  • Naushad SM, Reddy CA, Kumaraswami K, Divyya S, Kotamraju S, et al.: Impact of hyperhomocysteinemia on breast cancer initiation and progression: epigenetic perspective. Cell Biochem Biophys 68, 397–406, 2014.
  • Sun CF, Haven TR, Wu TL, Tsao KC, and Wu JT: Serum total homocysteine increases with the rapid proliferation rate of tumor cells and decline upon cell death: a potential new tumor marker. Clin Chim Acta 321, 55–62, 2002.
  • Refsum H, Wesenberg F, and Ueland PM: Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate. Cancer Res 51, 828–835, 1991.
  • Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, et al.: Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med 170, 1622, 2010.
  • De Vogel S, Wouters KAD, Gottschalk RWH, van Schooten FJ, de Goeij AFPM, et al.: Dietary methyl donors, methyl metabolizing enzymes,and epigenetic regulators: diet–gene interactions and promoter CpG island hypermethylation in colorectal cancer. Cancer Cause Control 22, 1–12, 2011.
  • Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, et al.: Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354, 1567–1577, 2006.
  • Lin J, Lee M, Song Y, Cook N, Selhub J, et al.: Plasma homocysteine and cysteine and risk of breast cancer in women. Cancer Res 70, 2397–2405, 2010.
  • Davis CD and Uthus EO: DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood) 229, 988–995, 2004.
  • Melnyk S, Pogribna M, Pogribny IP, Yi P, and James SJ: Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5’-phosphate concentrations. Clin Chem 46, 265–272, 2000.
  • Brattström L, Lindgren A, Israelsson B, Andersson A, and Hultberg B: Homocysteine and cysteine: determinants of plasma levels in middle aged and elderly subjects. J Int Med 236, 633–641, 1994.
  • Mahan LK, Escott-Stump S, and Raymond JL: Krause's Food and Nutrition Care Process (13th ed.). St. Louis, MO: Saunders, Elsevier Inc., 2012.
  • Wu K, Helzlsouer KJ, Comstock GW, Hoffman SC, Nadeau MR, et al.: A prospective study on folate, B12, and pyridoxal 5-phosphate (B6) and breast cancer. Cancer Epidemiol Biomarkers Prev 8, 209–217, 1999.
  • Shrubsole MJ, Jin F, Dai Q, Shu XO, Potter JD, et al.: Dietary folate intake and breast cancer risk results from the Shanghai Breast Cancer Study. Cancer Res 61, 7136–7141, 2001.
  • Rezaeiian F, Rashidkhani B, Mirzaei HR, Akbari E, Foroutan Ghaznavi M, Shadman Z, Houshiar-Rad A, Sanaat Z, Pirouzpanah S: Association between folate intake and breast cancer risk among Tehrani women: a case-control study. Iran J Nutr Food Sci 6, 21–31, 2012.
  • Chou YC, Wu MH, Yu JC, Lee MS, Yang T, et al.: Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case–control study in Taiwan. Carcinogenesis 27, 2295–2300, 2006.
  • Ho E, Beaver LM, Williams DE, and Dashwood RH: Dietary factors and epigenetic regulation for prostate cancer prevention. Adv Nutr 2, 497–510, 2011.
  • Zhang SM, Willett WC, Selhub J, Hunter DJ, Giovannucci EL, et al.: Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Ins 95, 373–380, 2003.
  • Yang D, Baumgartner RN, Slattery ML, Wang C, Giuliano AR, et al.: Dietary intake of folate, B-vitamins and methionine and breast cancer risk among Hispanic and non-Hispanic white women. PLoS One 8, e54495, 2013.
  • Lin J, Lee IM, Cook NR, Selhub J, Manson JAE, et al.: Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women. Am J Clin Nutr 87, 734–743, 2008.
  • Lajous M, Lazcano-Ponce E, Hernandez-Avila M, Willett W, and Romieu I: Folate, vitamin B6, and vitamin B12 intake and the risk of breast cancer among Mexican women. Cancer Epidemiology Biomarkers & Prevention 15, 443–448, 2006.
  • Breast cancer treatment. Available from: http://www.cancer.gov/cancertopics/pdq/treatment/breast/Patient/page2
  • Yi M, Mittendorf EA, Cormier JN, Buchholz TA, Bilimoria K, et al.: Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system. J Clin Oncol 29, 4654–4661, 2011.
  • How is breast cancer staged? Available from: http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-staging
  • Hashemian AH, Hajizadeh E, Kazemnejad A, Atri M, and Mehdipour P: Penetrance of BRCA1/BRCA2 specific gene mutations in Iranian women with breast cancer. Saudi Med J 30, 41–44, 2009.
  • Eckel R and Krauss R: American Heart Association call to action: obesity as a major risk factor for coronary heart disease. Circulation 97, 2099–2100, 1998.
  • Elshorbagy AK, Valdivia-Garcia M, Refsum H, and Butte N: The association of cysteine with obesity, inflammatory cytokines and insulin resistance in Hispanic children and adolescents. PLoS One 7, e44166, 2012.
  • Pirouzpanah S, Taleban FA, Sabour S, Mehdipour P, Atri M, et al.: Validation of food frequency questionnaire to assess folate intake status in breast cancer patients. Razi J Med Sci 18, 31–41, 2012.
  • Pirouzpanah S, Taleban FA, Mehdipour P, Atri M, Hooshyareh-rad A, et al.: The biomarker-based validity of a food frequency questionnaire to assess the intake status of folate, pyridoxine and cobalamin among Iranian primary breast cancer patients. Eur J Clin Nutr 68, 316–323, 2014.
  • Ghaffarpour M, Housyar-Rad A, and Kianfar T: The dietary guideline for converting the customary household utensil. Tehran: Keshaverzi Press, pp. 1–46, 1999 (in Farsi).
  • Willett W: Nutritional Epidemiology (2nd ed.). New York: Oxford University Press, 1998.
  • Goldberg GR, Black AE, Jebb SA, Cole TJ, Murgatroyd PR, et al.: Critical evaluation of energy intake data using fundamental principles of energy physiology: 1. Derivation of cut-off limits to identify under-recording. Eur J Clin Nutr 45, 569–581, 1991.
  • Black AE: Physical activity levels from a meta analysis of doubly labeled water studies for validating energy intake as measured by dietary assessment. Nutr Rev 54, 170–174, 1996.
  • Schofield WN: Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 39, 5–41, 1985.
  • Liu A, Lumeng L, Aronoff G, and Li TK: Relationship between body store of vitamin B6 and plasma pyridoxal-P clearance: metabolic balance studies in humans. J Lab Clin Med 106, 491–497, 1985.
  • Cheng CH, Tsai TP, Chen WS, and Huang YC: Serum folate is a reliable indicator of hyperhomocysteinemia and borderline hyperhomocysteinemia in young adults. Nutr Res 29, 743–749, 2009.
  • Ihara H, Watanabe T, Aoki Y, Nagamura Y, Totani M, et al.: Dietary folate intake and serum folate status in Japanese women of childbearing age. Journal of Analytical Bio-Science 32, 181–185, 2009.
  • Lui A, Lumeng L, Aronoff GR, and Ting-Kai LI: Relationship between body store of vitamin B6 and plasma pyridoxal-P clearance: metabolic balance studies in humans. J Lab Clin Med 106, 491–497, 1985.
  • van Asselt DZ, de Groot LC, van Staveren WA, Blom HJ, Wevers RA, et al.: Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr 68, 328–334, 1998
  • Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, et al.: Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354, 1567–1577, 2006.
  • Yoshihara RN, Teixeira BM, Adami F, Kuniyoshi RK, Alves BC, et al.: Circulating tumor cell detection during chemotherapy in patients with breast cancer is not associated with plasma homocysteine levels. Tumour Biol 34, 2937–2941, 2013.
  • Larsson SC, Giovannucci E, and Wolk A: Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 99, 64–76, 2007.
  • Gonda TA, Kim YI, Salas MC, Gamble MV, Shibata W, Muthupalani S, et al.: Folic acid increases global DNA methylation and reduces inflammation to prevent Helicobacter-associated gastric cancer in mice. Gastroenterol 142, 824–833, 2012.
  • O’Shannessy DJ, Somers EB, Maltzman J, Smale R, and Fu YS: Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease. SpringerPlus 1, 1–9, 2012.
  • De Bree A, Verschuren WMM, Bjrke-Monsen AL, van der Put NMJ, Heil SG, et al.: Effect of the methylenetetrahydrofolate reductase 677C→T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am J Clin Nutr 77, 687–693, 2003.
  • Sipponen P, Laxen F, Huotari K, and Härkönen M: Prevalence of low vitamin B12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection. Scand J Gastroenterol 38, 1209–1216, 2003.
  • Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, et al.: One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 29, 356–362, 2008.
  • Kim YI: Does a high folate intake increase the risk of breast cancer? Nutr Rev 64, 468–475, 2006.
  • Shimakawa T, Nieto FJ, Malinow MR, Chambless LE, Schreiner PJ, et al.: Vitamin intake: a possible determinant of plasma homocyst(e)ine among middle-aged adults. Ann Epidemiol 7, 285–293, 1997.
  • Zhang SM, Cook NR, Albert CM, Gaziano JM, Buring JE, et al.: Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA 300, 2012–2021, 2008.
  • Owens JE, Holstege DM, and Clifford AJ: Comparison of two dietary folate intake instruments and their validation by RBC folate. J Agric Food Chem 55, 3737–3740, 2007.
  • Mikkelsen TB, Osler M, and Olsen SF: Validity of protein, retinol, folic acid and n-3 fatty acid intakes estimated from the food-frequency questionnaire used in the Danish National Birth Cohort. Public Health Nutr 9, 771–778, 2006.
  • Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, et al.: Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122, 51–65, 1985.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.